tiprankstipranks
Advertisement
Advertisement

MGNX Stock Latest News

MacroGenics announces upcoming board change with director resignation
Company AnnouncementsMacroGenics announces upcoming board change with director resignation
11d ago
8K
MGNX
MacroGenics Completes Asset Sale, Shifts to R&D Focus
PremiumCompany Announcements
MacroGenics Completes Asset Sale, Shifts to R&D Focus
12d ago
8K
MGNX
MacroGenics to receive $24.5M milestone payment from Sanofi
PremiumThe Fly
MacroGenics to receive $24.5M milestone payment from Sanofi
27d ago
SNY
MGNX
MacroGenics Shareholders Back Board, Auditors and Equity Plan
PremiumCompany Announcements
MacroGenics Shareholders Back Board, Auditors and Equity Plan
2M ago
8K
MGNX
MacroGenics reports Q1 EPS (58c), consensus (55c)
PremiumThe Fly
MacroGenics reports Q1 EPS (58c), consensus (55c)
2M ago
MGNX
MacroGenics Sells Maryland Biologics Manufacturing to Bora
PremiumCompany AnnouncementsMacroGenics Sells Maryland Biologics Manufacturing to Bora
2M ago
8K
MGNX
MacroGenics to sell GMP manufacturing operations to Bora for $122.5M upfront
Premium
The Fly
MacroGenics to sell GMP manufacturing operations to Bora for $122.5M upfront
2M ago
MGNX
MacroGenics trading resumes
Premium
The Fly
MacroGenics trading resumes
2M ago
MGNX
MacroGenics trading halted, news pending
PremiumThe Fly
MacroGenics trading halted, news pending
2M ago
MGNX
Is MGNX a Buy, Before Earnings?
PremiumPre-Earnings
Is MGNX a Buy, Before Earnings?
2M ago
MGNX
MacroGenics Expands ZYNYZ Royalty Agreement for Added Funding
PremiumCompany Announcements
MacroGenics Expands ZYNYZ Royalty Agreement for Added Funding
3M ago
8K
MGNX
MacroGenics, Sagard enter expanded Zynyz royalty purchase agreement
PremiumThe Fly
MacroGenics, Sagard enter expanded Zynyz royalty purchase agreement
3M ago
INCY
MGNX
MacroGenics price target raised to $6 from $4 at Barclays
PremiumThe FlyMacroGenics price target raised to $6 from $4 at Barclays
3M ago
MGNX
MacroGenics Nears Key Prostate Cancer Catalyst as Phase 2 Lorigerlimab Trial Completes
Premium
Company Announcements
MacroGenics Nears Key Prostate Cancer Catalyst as Phase 2 Lorigerlimab Trial Completes
3M ago
MGNX
MacroGenics upgraded to Buy at B. Riley after deal for Tubulus
Premium
The Fly
MacroGenics upgraded to Buy at B. Riley after deal for Tubulus
3M ago
GILD
MGNX
MacroGenics upgraded to Buy from Neutral at B. Riley
PremiumThe Fly
MacroGenics upgraded to Buy from Neutral at B. Riley
3M ago
MGNX
MacroGenics Resumes LINNET Trial After FDA Hold Lifted
PremiumCompany Announcements
MacroGenics Resumes LINNET Trial After FDA Hold Lifted
3M ago
8K
MGNX
MacroGenics says FDA removes partial clinical hold on Phase 2 LINNET study
PremiumThe Fly
MacroGenics says FDA removes partial clinical hold on Phase 2 LINNET study
3M ago
MGNX
MacroGenics price target raised to $4 from $3 at Barclays
PremiumThe Fly
MacroGenics price target raised to $4 from $3 at Barclays
4M ago
MGNX
FDA Places Partial Clinical Hold on MacroGenics Trial
PremiumCompany AnnouncementsFDA Places Partial Clinical Hold on MacroGenics Trial
5M ago
8K
MGNX
MacroGenics says FDA places partial clinical hold on Phase 2 LINNET study
Premium
The Fly
MacroGenics says FDA places partial clinical hold on Phase 2 LINNET study
5M ago
MGNX
MacroGenics Inc (MGNX) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
MacroGenics Inc (MGNX) Q4 Earnings Cheat Sheet
5M ago
MGNX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >